|
| | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide Basic information |
| Product Name: | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide | | Synonyms: | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide;Glycinamide, N-[[3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-N-methylglycyl-N,N,N2-trimethyl- (9CI);KD 027;KD027;KD-027 | | CAS: | 906421-01-0 | | MF: | C25H35N7O6S | | MW: | 561.65 | | EINECS: | | | Product Categories: | | | Mol File: | 906421-01-0.mol | ![N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide Structure](CAS/20200611/GIF/906421-01-0.gif) |
| | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide Chemical Properties |
| | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide Usage And Synthesis |
| Description | KD-027, also known as SLx-2101, is a PDE5A inhibitor potentially for the treatment of hypertension. |
| | N-(2-(dimethylamino)-2-oxoethyl)-2-(4-ethoxy-N-methyl-3-(5-methyl-4-oxo-7-propyl-3,4-dihydroimidazo[5,1-f][1,2,4]triazin-2-yl)phenylsulfonamido)-N-methylacetamide Preparation Products And Raw materials |
|
